Evaluation of Flow Diverter Technology Device for Intracranial Aneurysm (SHIELD)

Last updated: March 6, 2026
Sponsor: Jacobs institute
Overall Status: Active - Recruiting

Phase

N/A

Condition

Aneurysm

Treatment

SHIELD

Clinical Study ID

NCT06793059
SHIELD 30 DAY CIP-001
SHIELD
  • Ages > 22
  • All Genders

Study Summary

The Jacobs Institute is participating in a study designed to collect prospective clinical evidence to evaluate the approved use of the Pipeline™ Flex Embolization Device with Shield Technology™ for the endovascular treatment of adults (22 years of age or older) with wide-necked intracranial aneurysms

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Adults (22 years of age or older) with large or giant wide-necked intracranialaneurysms (IAs) in the internal carotid artery from the petrous to the superiorhypophyseal segments.

Exclusion

Exclusion Criteria:

Exclusion Criteria:

  • Cannot provide consent or legally authorized representative not available to provideconsent Criteria:

Study Design

Total Participants: 10
Treatment Group(s): 1
Primary Treatment: SHIELD
Phase:
Study Start date:
January 01, 2025
Estimated Completion Date:
January 01, 2027

Study Description

The Pipeline™ Flex Embolization Device with Shield Technology™ for the endovascular treatment of adults (22 years of age or older) with large or giant wide-necked intracranial aneurysms (IAs) in the internal carotid artery from the petrous to the superior hypophyseal segments. The Pipeline™ Flex Embolization Device with Shield Technology™ is also indicated for use in the internal carotid artery up to the terminus for the endovascular treatment of adults (22 years of age or older) with small and medium wide-necked (neck width ≥ 4 mm or dome-to-neck ratio < 2) saccular or fusiform intracranial aneurysm (IAs) arising from a parent vessel with a diameter ≥ 2.0 mm and ≤ 5.0 mm.

Connect with a study center

  • Jacobs Institute

    Buffalo, New York 14203
    United States

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.